Mild traumatic brain injury (mTBI) is the most common form of TBI, with more than 2.5 million TBI cases in the United States annually. Identification of easily obtainable biomarkers that track strongly with mTBI symptoms may improve our understanding of biological factors that contribute to mTBI symptom profiles and long-term outcomes. Notably, some individuals with mTBI exhibit circadian disruptions and elevated stress sensitivity, which in other clinical groups often correlate with disrupted secretion of cortisol, a glucocorticoid hormone that coordinates circadian and stress physiology. Here, we examined whether cortisol profiles could serve as a biomarker to complement the assessment of neurobehavioral sequelae after mTBI. We partnered with our on-campus health clinic to recruit college students seeking medical care after mTBI (n = 46) and compared this population to a well-matched non-injured student control group (n = 44). We collected data at an initial visit (shortly after injury in mTBI subjects) and one week later. At each visit, we evaluated neurobehavioral function using the Automated Neuropsychological Assessment Metric (ANAM). The subjects also provided cortisol samples through at-home saliva collection. We observed strong coherence between ANAM subjective and objective measures, indicating significant multi-dimensional impairment in subjects with mTBI. Further, female mTBI subjects exhibited diminished neurobehavioral function compared with males. Regardless of sex, decreased amplitude of diurnal cortisol and a blunted cortisol awakening response were associated with mTBI symptom severity and neurobehavioral impairment. Taken together, these findings suggest that salivary cortisol profiles may be a sensitive biomarker for studying underlying biological factors that impact mTBI symptoms and outcomes.
Get full access to this article
View all access options for this article.
References
1.
TaylorC.A., BellJ.M., BreidingM.J., and XuL. (2017). Traumatic brain injury–related emergency department visits, hospitalizations, and deaths United States, 2007 and 2013. MMWR. Surveillance Summaries, 66, 1–16.
2.
ChoeM.C. (2016). The pathophysiology of concussion. Curr. Pain Headache Rep. 20, 42.
3.
LakerS.R. (2011). Epidemiology of concussion and mild traumatic brain injury. PM R 3, Suppl. 2, S354–S358. 4..
4.
KayT (1993). Neuropsychological treatment of mild traumatic brain injury. J. Head Trauma Rehabil. 8, 74–85.
5.
SharpD.J., and JenkinsP.O. (2015). Concussion is confusing us all. Pract. Neurol. 15, 172–186.
6.
RutherfordW.H., MerrettJ.D., and McDonaldJ.R. (1979). Symptoms at one year following concussion from minor head injuries. Injury, 10, 225–230.
7.
SpinosP., SakellaropoulosG., GeorgiopoulosM., StavridiK., ApostolopoulouK., EllulJ., and ConstantoyannisC. (2010). Postconcussion syndrome after mild traumatic brain injury in Western Greece. J. Trauma, 69, 789–794.
8.
ArrieuxJ.P., ColeW.R., and AhrensA.P. (2017). A review of the validity of computerized neurocognitive assessment tools in mild traumatic brain injury assessment. Concussion 2,CNC31.
9.
ReevesD.L., WinterK.P., BleibergJ., and KaneR.L. (2007). ANAM® Genogram: historical perspectives, description, and current endeavors. Arch Clin. Neuropsychol. 22, Suppl. 1, S15–S37.
10.
Register-MihalikJ.K. , GuskiewiczK.M., MihalikJ.P., SchmidtJ.D., KerrZ.Y., and McCreaM.A. (2013). Reliable change, sensitivity, and specificity of a multidimensional concussion assessment battery: implications for caution in clinical practice. J. Head Trauma Rehabil. 28, 274–283.
11.
NelsonL.D., LaRocheA.A., PfallerA.Y., LernerE.B., HammekeT.A., RandolphC., BarrW.B., GuskiewiczK., and McCreaM.A. (2016). Prospective, head-to-head study of three computerized Neurocognitive Assessment Tools (CNTs): reliability and validity for the assessment of sport-related concussion. J. Int. Neuropsychol. Soc. 22, 24–37.
12.
KaneR.L., Roebuck-SpencerT., ShortP., KabatM., and WilkenJ. (2007). Identifying and monitoring cognitive deficits in clinical populations using Automated Neuropsychological Assessment Metrics (ANAM) tests. Arch. Clin. Neuropsychol. 22, Suppl. 1, S115–S126.
13.
LevinH.S., and Diaz-ArrastiaR.R. (2015). Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol. 14, 506–517.
14.
MayerAR, QuinnDK, and Master CL (2017) The spectrum of mild traumatic brain injury: a review. Neurology 89, 623–632.
15.
DadasA., WashingtonJ., Diaz-ArrastiaR., and JanigroD. (2018) Biomarkers in traumatic brain injury (TBI): a review. Neuropsychiatric disease and treatment 14, 2989–3000.
16.
KimH.J., TsaoJ.W., and StanfillA.G. (2018). The current state of biomarkers of mild traumatic brain injury. JCI insight, 3, e97105.
17.
SpencerR.L., and DeakT. (2017). A users guide to HPA axis research. Physiology and, Behavior, 178, 43–65.
18.
SpencerR.L., ChunL.E., HartsockM.J., and WoodruffE.R. (2020). Neurobiology of stress-health relationships, in: Cohen, L.M., ed. The Encyclopedia of Health Psychology,. L.M. Cohen (ed). Wiley-Blackwell: Hoboken, NJ, pp. 21–35.
19.
ClowA., ThornL., EvansP., HucklebridgeF. (2004). The awakening cortisol response: methodological issues and significance. Stress, 7, 29–37.
20.
PruessnerJ.C., WolfO.T., HellhammerD.H., Buske-KirschbaumA., Von AuerK., JobstS., KaspersF., and KirschbaumC. (1997). Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61, 2539–2549.
21.
SpencerR. L., ChunL. E., HartsockM. J., WoodruffE. R. (2017). Glucocorticoid hormones are both a major circadian signal and major stress signal: how this shared signal contributes to a dynamic relationship between the circadian and stress systems. Front. Neuroendocrinol. 49, 52–71.
22.
BuijsR.M., and EscobarC. (2007). Corticosterone and activity: the long arms of the clock talk back. Endocrinology, 148, 5162–5164.
23.
WilhelmI., BornJ., KudielkaB.M., SchlotzW., and WustS. (2007). Is the cortisol awakening rise a response to awakening?. Psychoneuroendocrinology, 32, 358–366.
24.
FriesE., DettenbornL., and KirschbaumC. (2009). The cortisol awakening response (CAR): facts and future directions. Int. J. Psychophysiol. 72, 67–73.
25.
ClowA., HucklebridgeF., StalderT., EvansP., and ThornL. (2010). The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 35, 97–103.
26.
AdamE.K., QuinnM.E., TavernierR., McQuillanM.T., DahlkeK.A., and GilbertK.E. (2017). Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology, 83, 25–41.
27.
ChidaY., and SteptoeA. (2009). Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol. Psychol. 80, 265–278.
28.
KudielkaB., and KirschbaumC. (2003). Awakening cortisol responses are influence by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology, 28, 35–47.
29.
CarolE.E., and MittalV.A. (2015) Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders. Psychoneuroendocrinology 57, 26–36.
30.
WickwireE.M., SchcnyerD.M., GermainA., SmithM.T., WilliamsS.G., LettieriC.J., McKeonA.B., ScharfS.M., StockerR., AlbrechtJ., BadjatiaN., MarkowitzA.J., and ManleyG.T. (2018). Sleep, sleep disorders, and circadian health following mild traumatic brain injury in adults: review and research agenda. J. Neurotrauma, 35, 2615–2631.
31.
HutchisonM.G., MainwaringL., SenthinathanA., ChurchillN., ThomasS., and RichardsD. (2017). Psychological and physiological markers of stress in concussed athletes across recovery milestones. J. Head Trauma Rehabil. 32, E38–E48.
32.
BreckJ., BohrA., PoddarS., McQueenM.B., and CasaultT. (2019). Characteristics and incidence of concussion among a US collegiate undergraduate population. JAMA Netw. Open, 2, e1917626.
33.
VincentA.S., Roebuck-SpencerT.M., Cox-FuenzalidaL.E., BlockC., ScottJ.G., and KaneR. (2018). Validation of ANAM for cognitive screening in a mixed clinical sample. Appl. Neuropsychol. Adult, 25, 366–375.
34.
AardalE., and HolmA.C. (1995). Cortisol in saliva—reference ranges and relation to cortisol in serum. Eur. J. Chem. Clin. Biochem. 33, 927–932.
35.
BleibergJ., KaneR.L., ReevesD.L., GarmoeW.S., and HalpernE. (2000). Factor analysis of computerized and traditional tests used in mild brain injury research. Clin. Neuropsychol. 14, 287–294.
36.
CovassinT., ElbinR.J., HarrisW., ParkerT. and KontosA. (2012). The role of age and sex in symptoms, neurocognitive performance, and postural stability in athletes after concussion. Am. J. Sports Med. 40, 1303–1312.
37.
AlsalaheenB., AlmeidaA., EcknerJ., FreemanJ., IchescoI., PopovichM., StreicherN., and LorinczM. (2021). Do male and female adolescents report symptoms differently after concussion?. Brain Inj. 35, 698–704.
38.
KroshusE., BaughC.M., SteinC.J., AustinS.B., and CalzoJ.P. (2017). Concussion reporting, sex, and conformity to traditional gender norms in young adults. J. Adolesc. 54, 110–119.
39.
BazarianJ.J., BlythB., MookerjeeS., HeH., and McDermottM.P. (2010). Sex differences in outcome after mild traumatic brain injury. J. Neurotrauma, 27, 527–539.
40.
StyrkeJ., SojkaP., BjörnstigU., BylundP.O., and StålnackeB.M. (2013). Sex differences in symptoms, disability, and life satisfaction three years after mild traumatic brain injury: a population-based cohort study. J. Rehabil. Med. 45, 749–757.
41.
HsuH.L., ChenD.Y. T., TsengY.C., KuoY.S., HuangY.L., ChiuW.T., YanF.X., WangW.S., and ChenC.J. (2015). Sex differences in working memory after mild traumatic brain injury: a functional MR imaging study. Radiology, 276, 828–835.
42.
GupteR.P., BrooksW.M., VukasR.R., PierceJ.D., and HarrisJ.L. (2019). Sex differences in traumatic brain injury: what we know and what we should know. J. Neurotrauma, 36, 3063–3091.
43.
LevinH.S., TemkinN.R., BarberJ., NelsonA.D., RobertsonC., BrennanJ., SteinM.B., YueJ.K., GiacinoJ.T., McCreaM.A., Diaz-ArrastiaR., MukherjeeP., OkonkwoD.O., BoaseK., MarkowitzAJ., Bodien,Y., TaylorS., VassarM.J., ManleyG.T., and the TRACK-BIInvestigators. (2021). Association of sex and age with mild traumatic brain injury–related symptoms: a TRACK-TBI study. JAMA Netw. Open, 4, e213046.
44.
RauchS.A.M., KingA., Myra KimH., PowellC., RajaramN., VennersM., SimonN. M., HanmerM., and LiberzonI. (2020). Cortisol awakening response in PTSD treatment: Predictor or mechanism of change. Psychoneuroendocrinology, 118, 104714.
45.
Ancoli-IsraelS., ColeR., AlessiC., ChambersM., MoocroftW., and PollakC. (2003). The role of actigraphy in the study of sleep and circadian rhythms. Sleep, 26, 342–392.
46.
DaskalakisN.P., LehrnerA., and YehudaR. (2013). Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment. Endocrinol. Metab. Clin. North Am. 42, 503–513.
47.
BayE., SikorskiiA., and GaoF. (2009). Functional status, chronic stress, and cortisol response after mild-to-moderate traumatic brain injury. Biol. Res. Nurs. 10, 213–225.
48.
HogeC.W., McGurkD., ThomasJ.T., CoxA.L., EngelC.C., and CastroC.A. (2008). Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N. Engl. J Med. 358, 453–463.
49.
SteinM.B., KesslerR.C., HeeringaS.G., JainS., Campbell-SillsL., ColpeL.J., FullertonC.S., NockM.K., SampsonN.A., SchoenbaumM., SunX., ThomasM.L., UrsanoR.J., ArmySTARRS collaborators. (2015). Prospective longitudinal evaluation of the effect of deployment-acquired traumatic brain injury on posttraumatic stress and related disorders: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). Am. J. Psychiatry, 172, 1101–1111.
50.
BalsalobreA., BrownS.A., MarcacciL., TroncheF., KellendonkC., ReichardtH.M., SchutzG., and SchiblerU. (2000). Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science, 289, 2344–2347.
51.
DickmeisT. (2009). Glucocorticoids and the circadian clock. J. Endocrinol. 200, 3–22.
52.
OsterH., ChalletE., OttV., ArvatE., Ronald de KloetE., DijkD. J., LightmanS., VgontzasA., and Van CauterE. (2017). The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr. Rev. 38, 3–45.
53.
WoodruffE.R., ChunL.E., HindsL.R., and SpencerR.L. (2016). Diurnal corticosterone presence and phase modulate clock gene expression in the male rat prefrontal cortex. Endocrinology, 157, 1522–1534.
54.
WoodruffE.R., ChunL.E., HindsL.R., VarraN.M., TiradoD., MortonS.J., McClungC.A., and SpencerR.L. (2018). Coordination between prefrontal cortex clock gene expression and corticosterone contributes to enhanced conditioned fear extinction recall. eNeuro, 5, e0455–18.2018.
55.
HernándezT.D., BrennerL.A., WalterK.H., BormannJ.E., and JohanssonB. (2016). Complementary and alternative medicine (CAM) following traumatic brain injury (TBI): opportunities and challenges. Brain Res. 1640, 139–151.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
